Exelixis, Inc. (EXEL) Stock Forecast
EXEL analyst forecast
as of October 18, 2026- Analyst consensus
- Buy 3.67 / 5 from 18 analysts
- Price target
- $54.87 average of analyst targets
- Upside to target
- −11.8% from the latest close
- Next earnings
- November 3, 2026 EPS estimate $0.79
- 52-week range
- $34.54 – $62.83
EXEL analyst ratings
18 analystsNumber of analysts at each rating.
EXEL price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
EXEL earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.90 | $0.81 | $0.96 | $0.78 | +15.0% | 9 |
| Current fiscal year (2026) | $3.58 | $3.25 | $3.77 | $3.08 | +16.4% | 10 |
| Next fiscal year (2027) | $4.27 | $3.74 | $5.41 | $3.58 | +19.2% | 10 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
EXEL revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $649.7M | $636.2M | $667.6M | +8.7% | 15 |
| Current fiscal year (2026) | $2.55B | $2.53B | $2.61B | +10.1% | 17 |
| Next fiscal year (2027) | $2.90B | $2.60B | $3.10B | +13.6% | 16 |
EXEL EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
EXEL revenue: reported and forecast
EXEL EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.88 | $0.91 | $0.91 | $0.90 | $0.90 | +1.4% | 1 up · 2 down |
| Current fiscal year (2026) | $3.53 | $3.57 | $3.58 | $3.58 | $3.58 | +1.6% | 1 up · 2 down |
| Next fiscal year (2027) | $3.96 | $4.07 | $4.26 | $4.23 | $4.27 | +7.9% | 3 up · 1 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
EXEL earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; EXEL beat in 10 of 12.
What analysts expect from EXEL
18 analysts cover Exelixis; their consensus rating is buy (3.67 on a 1–5 scale, where 5 is a strong buy). The average price target is $54.87, 11.8% below the latest close of $62.23. Analysts expect earnings of $3.58 per share for 2026, +16.4% from a year earlier. For 2027 the average estimate is $4.27 per share on revenue of $2.9 billion. Exelixis beat the EPS estimate in 10 of the last 12 quarters.
Related: EXEL income statement, EXEL key metrics, EXEL chart. See the EXEL stock overview for the latest quote and news.
EXEL forecast FAQ
What is Exelixis's price target?
The average analyst price target for Exelixis is $54.87, 11.8% below the latest close of $62.23.
Is Exelixis a buy, hold or sell?
Of 18 analysts covering Exelixis, 6 rate it a strong buy, 1 a buy, 10 a hold, 1 a sell and 0 a strong sell, a consensus of buy. Ratings are opinions, not a recommendation from Quotelinks.
What is Exelixis's EPS forecast?
Analysts forecast $3.58 per share for 2026 (range $3.25 to $3.77); for 2027 the estimate is $4.27.
What is Exelixis's revenue forecast?
The average revenue estimate for 2026 is $2.6 billion, growth of 10.1%; for 2027 it is $2.9 billion.
When does Exelixis report earnings?
Exelixis is expected to report results for the quarter ending September 30, 2026 on November 3, 2026; the EPS estimate is $0.79.
Does Exelixis usually beat earnings estimates?
Exelixis reported EPS at or above the analyst estimate in 10 of the last 12 quarters.